151
|
Trapotsi MA, Mervin LH, Afzal AM, Sturm N, Engkvist O, Barrett IP, Bender A. Comparison of Chemical Structure and Cell Morphology Information for Multitask Bioactivity Predictions. J Chem Inf Model 2021; 61:1444-1456. [PMID: 33661004 DOI: 10.1021/acs.jcim.0c00864] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The understanding of the mechanism-of-action (MoA) of compounds and the prediction of potential drug targets play an important role in small-molecule drug discovery. The aim of this work was to compare chemical and cell morphology information for bioactivity prediction. The comparison was performed using bioactivity data from the ExCAPE database, image data (in the form of CellProfiler features) from the Cell Painting data set (the largest publicly available data set of cell images with ∼30,000 compound perturbations), and extended connectivity fingerprints (ECFPs) using the multitask Bayesian matrix factorization (BMF) approach Macau. We found that the BMF Macau and random forest (RF) performance were overall similar when ECFPs were used as compound descriptors. However, BMF Macau outperformed RF in 159 out of 224 targets (71%) when image data were used as compound information. Using BMF Macau, 100 (corresponding to about 45%) and 90 (about 40%) of the 224 targets were predicted with high predictive performance (AUC > 0.8) with ECFP data and image data as side information, respectively. There were targets better predicted by image data as side information, such as β-catenin, and others better predicted by fingerprint-based side information, such as proteins belonging to the G-protein-Coupled Receptor 1 family, which could be rationalized from the underlying data distributions in each descriptor domain. In conclusion, both cell morphology changes and chemical structure information contain information about compound bioactivity, which is also partially complementary, and can hence contribute to in silico MoA analysis.
Collapse
Affiliation(s)
- Maria-Anna Trapotsi
- Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K
| | - Lewis H Mervin
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K
| | - Avid M Afzal
- Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K
| | - Noé Sturm
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-43183, Sweden
| | - Ola Engkvist
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg SE-43183, Sweden
| | - Ian P Barrett
- Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K
| | - Andreas Bender
- Department of Chemistry, Centre for Molecular Informatics, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K
| |
Collapse
|
152
|
Narayanan H, Dingfelder F, Butté A, Lorenzen N, Sokolov M, Arosio P. Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation. Trends Pharmacol Sci 2021; 42:151-165. [DOI: 10.1016/j.tips.2020.12.004] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Revised: 12/10/2020] [Accepted: 12/16/2020] [Indexed: 12/19/2022]
|
153
|
Shen WX, Zeng X, Zhu F, Wang YL, Qin C, Tan Y, Jiang YY, Chen YZ. Out-of-the-box deep learning prediction of pharmaceutical properties by broadly learned knowledge-based molecular representations. NAT MACH INTELL 2021. [DOI: 10.1038/s42256-021-00301-6] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
154
|
Liang S, Yu H. Revealing new therapeutic opportunities through drug target prediction: a class imbalance-tolerant machine learning approach. Bioinformatics 2021; 36:4490-4497. [PMID: 32399556 DOI: 10.1093/bioinformatics/btaa495] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 02/18/2020] [Accepted: 05/06/2020] [Indexed: 11/12/2022] Open
Abstract
MOTIVATION In silico drug target prediction provides valuable information for drug repurposing, understanding of side effects as well as expansion of the druggable genome. In particular, discovery of actionable drug targets is critical to developing targeted therapies for diseases. RESULTS Here, we develop a robust method for drug target prediction by leveraging a class imbalance-tolerant machine learning framework with a novel training scheme. We incorporate novel features, including drug-gene phenotype similarity and gene expression profile similarity that capture information orthogonal to other features. We show that our classifier achieves robust performance and is able to predict gene targets for new drugs as well as drugs that potentially target unexplored genes. By providing newly predicted drug-target associations, we uncover novel opportunities of drug repurposing that may benefit cancer treatment through action on either known drug targets or currently undrugged genes. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.
Collapse
Affiliation(s)
- Siqi Liang
- Department of Computational Biology, Cornell University, Ithaca, NY 14853, USA.,Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA
| | - Haiyuan Yu
- Department of Computational Biology, Cornell University, Ithaca, NY 14853, USA.,Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853, USA
| |
Collapse
|
155
|
Jiang D, Wu Z, Hsieh CY, Chen G, Liao B, Wang Z, Shen C, Cao D, Wu J, Hou T. Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models. J Cheminform 2021; 13:12. [PMID: 33597034 PMCID: PMC7888189 DOI: 10.1186/s13321-020-00479-8] [Citation(s) in RCA: 162] [Impact Index Per Article: 54.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Accepted: 11/26/2020] [Indexed: 12/31/2022] Open
Abstract
Graph neural networks (GNN) has been considered as an attractive modelling method for molecular property prediction, and numerous studies have shown that GNN could yield more promising results than traditional descriptor-based methods. In this study, based on 11 public datasets covering various property endpoints, the predictive capacity and computational efficiency of the prediction models developed by eight machine learning (ML) algorithms, including four descriptor-based models (SVM, XGBoost, RF and DNN) and four graph-based models (GCN, GAT, MPNN and Attentive FP), were extensively tested and compared. The results demonstrate that on average the descriptor-based models outperform the graph-based models in terms of prediction accuracy and computational efficiency. SVM generally achieves the best predictions for the regression tasks. Both RF and XGBoost can achieve reliable predictions for the classification tasks, and some of the graph-based models, such as Attentive FP and GCN, can yield outstanding performance for a fraction of larger or multi-task datasets. In terms of computational cost, XGBoost and RF are the two most efficient algorithms and only need a few seconds to train a model even for a large dataset. The model interpretations by the SHAP method can effectively explore the established domain knowledge for the descriptor-based models. Finally, we explored use of these models for virtual screening (VS) towards HIV and demonstrated that different ML algorithms offer diverse VS profiles. All in all, we believe that the off-the-shelf descriptor-based models still can be directly employed to accurately predict various chemical endpoints with excellent computability and interpretability.![]()
Collapse
Affiliation(s)
- Dejun Jiang
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China.,State Key Lab of CAD & CG, Zhejiang University, Hangzhou, 310058, Zhejiang, China.,College of Computer Science and Technology, Zhejiang University, Hangzhou, China
| | - Zhenxing Wu
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China
| | - Chang-Yu Hsieh
- Tencent Quantum Laboratory Tencent, Shenzhen, 518057, Guangdong, China
| | - Guangyong Chen
- Shenzhen Institutes of Advanced Technology, Shenzhen, 518055, Guangdong, China
| | - Ben Liao
- Tencent Quantum Laboratory Tencent, Shenzhen, 518057, Guangdong, China
| | - Zhe Wang
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China
| | - Chao Shen
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China
| | - Dongsheng Cao
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410004, Hunan, China.
| | - Jian Wu
- College of Computer Science and Technology, Zhejiang University, Hangzhou, China.
| | - Tingjun Hou
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China. .,State Key Lab of CAD & CG, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
| |
Collapse
|
156
|
Evaluation of multi-target deep neural network models for compound potency prediction under increasingly challenging test conditions. J Comput Aided Mol Des 2021; 35:285-295. [PMID: 33598870 PMCID: PMC7982389 DOI: 10.1007/s10822-021-00376-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Accepted: 02/03/2021] [Indexed: 11/25/2022]
Abstract
Machine learning (ML) enables modeling of quantitative structure–activity relationships (QSAR) and compound potency predictions. Recently, multi-target QSAR models have been gaining increasing attention. Simultaneous compound potency predictions for multiple targets can be carried out using ensembles of independently derived target-based QSAR models or in a more integrated and advanced manner using multi-target deep neural networks (MT-DNNs). Herein, single-target and multi-target ML models were systematically compared on a large scale in compound potency value predictions for 270 human targets. By design, this large-magnitude evaluation has been a special feature of our study. To these ends, MT-DNN, single-target DNN (ST-DNN), support vector regression (SVR), and random forest regression (RFR) models were implemented. Different test systems were defined to benchmark these ML methods under conditions of varying complexity. Source compounds were divided into training and test sets in a compound- or analog series-based manner taking target information into account. Data partitioning approaches used for model training and evaluation were shown to influence the relative performance of ML methods, especially for the most challenging compound data sets. For example, the performance of MT-DNNs with per-target models yielded superior performance compared to single-target models. For a test compound or its analogs, the availability of potency measurements for multiple targets affected model performance, revealing the influence of ML synergies.
Collapse
|
157
|
Santana MVS, Silva-Jr FP. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 2021; 15:8. [PMID: 33531083 PMCID: PMC7852053 DOI: 10.1186/s13065-021-00737-2] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Accepted: 01/16/2021] [Indexed: 12/13/2022] Open
Abstract
The global pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) created a rush to discover drug candidates. Despite the efforts, so far no vaccine or drug has been approved for treatment. Artificial intelligence offers solutions that could accelerate the discovery and optimization of new antivirals, especially in the current scenario dominated by the scarcity of compounds active against SARS-CoV-2. The main protease (Mpro) of SARS-CoV-2 is an attractive target for drug discovery due to the absence in humans and the essential role in viral replication. In this work, we developed a deep learning platform for de novo design of putative inhibitors of SARS-CoV-2 main protease (Mpro). Our methodology consists of 3 main steps: (1) training and validation of general chemistry-based generative model; (2) fine-tuning of the generative model for the chemical space of SARS-CoV- Mpro inhibitors and (3) training of a classifier for bioactivity prediction using transfer learning. The fine-tuned chemical model generated > 90% valid, diverse and novel (not present on the training set) structures. The generated molecules showed a good overlap with Mpro chemical space, displaying similar physicochemical properties and chemical structures. In addition, novel scaffolds were also generated, showing the potential to explore new chemical series. The classification model outperformed the baseline area under the precision-recall curve, showing it can be used for prediction. In addition, the model also outperformed the freely available model Chemprop on an external test set of fragments screened against SARS-CoV-2 Mpro, showing its potential to identify putative antivirals to tackle the COVID-19 pandemic. Finally, among the top-20 predicted hits, we identified nine hits via molecular docking displaying binding poses and interactions similar to experimentally validated inhibitors.
Collapse
Affiliation(s)
- Marcos V S Santana
- LaBECFar-Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, 21040-900, Brazil
| | - Floriano P Silva-Jr
- LaBECFar-Laboratório de Bioquímica Experimental e Computacional de Fármacos, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, 21040-900, Brazil.
| |
Collapse
|
158
|
Pan Y, Chen Z, Qi F, Liu J. Identification of drug compounds for keloids and hypertrophic scars: drug discovery based on text mining and DeepPurpose. ANNALS OF TRANSLATIONAL MEDICINE 2021; 9:347. [PMID: 33708974 PMCID: PMC7944324 DOI: 10.21037/atm-21-218] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Background Keloids (KL) and hypertrophic scars (HS) are forms of abnormal cutaneous scarring characterized by excessive deposition of extracellular matrix and fibroblast proliferation. Currently, the efficacy of drug therapies for KL and HS is limited. The present study aimed to investigate new drug therapies for KL and HS by using computational methods. Methods Text mining and GeneCodis were used to mine genes closely related to KL and HS. Protein-protein interaction analysis was performed using Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and Cytoscape. The selection of drugs targeting the genes closely related to KL and HS was carried out using Pharmaprojects. Drug-target interaction prediction was performed using DeepPurpose, through which candidate drugs with the highest predicted binding affinity were finally obtained. Results Our analysis using text mining identified 69 KL- and HS-related genes. Gene enrichment analysis generated 25 genes, representing 7 pathways and 130 targeting drugs. DeepPurpose recommended 14 drugs as the final drug list, including 2 phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitors, 10 prostaglandin-endoperoxide synthase 2 (PTGS2) inhibitors and 2 vascular endothelial growth factor A (VEGFA) antagonists. Conclusions Drug discovery using in silico text mining and DeepPurpose may be a powerful and effective way to identify drugs targeting the genes related to KL and HS.
Collapse
Affiliation(s)
- Yuyan Pan
- Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Zhiwei Chen
- Big Data and Artificial Intelligence Center, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Fazhi Qi
- Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
| | - Jiaqi Liu
- Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.,Artificial Intelligence Center for Plastic Surgery and Cutaneous Soft Tissue Cancers, Zhongshan Hospital, Fudan University, Shanghai, China
| |
Collapse
|
159
|
Menke J, Koch O. Using Domain-Specific Fingerprints Generated Through Neural Networks to Enhance Ligand-Based Virtual Screening. J Chem Inf Model 2021; 61:664-675. [PMID: 33497572 DOI: 10.1021/acs.jcim.0c01208] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Similarity-based virtual screening is a fundamental tool in the early drug discovery process and relies heavily on molecular fingerprints. We propose a novel strategy of generating domain-specific fingerprints by training neural networks on target-specific bioactivity datasets and using the activation as a new molecular representation. The neural network is expected to combine information of already known bioactive compounds with unique information of the molecular structure and by doing so enrich the fingerprint. We evaluate this strategy on a large kinase-specific bioactivity dataset. A comparison of five neural network architectures and their fingerprints to the well-established extended-connectivity fingerprint (ECFP) and an autoencoder shows that our neural fingerprint produces better results in the similarity search. Most importantly, the neural fingerprint performs well even when specific targets are not included during training. Surprisingly, while Graph Neural Networks (GNNs) are thought to offer an advantageous alternative, the best performing neural fingerprints were based on traditional fully connected layers using the ECFP4 as the input. The neural fingerprint is freely available at: https://github.com/kochgroup/kinase_nnfp.
Collapse
Affiliation(s)
- Janosch Menke
- Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Corrensstraße 48, Münster 48149, Germany
| | - Oliver Koch
- Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Corrensstraße 48, Münster 48149, Germany.,Center for Multiscale Theory and Computation, Westfälische Wilhelms-Universität Münster, Corrensstraße 48, Münster 48149, Germany
| |
Collapse
|
160
|
Liang L, Rasmussen MLH, Piening B, Shen X, Chen S, Röst H, Snyder JK, Tibshirani R, Skotte L, Lee NC, Contrepois K, Feenstra B, Zackriah H, Snyder M, Melbye M. Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant Women. Cell 2021; 181:1680-1692.e15. [PMID: 32589958 PMCID: PMC7327522 DOI: 10.1016/j.cell.2020.05.002] [Citation(s) in RCA: 140] [Impact Index Per Article: 46.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2018] [Revised: 03/11/2020] [Accepted: 04/29/2020] [Indexed: 01/10/2023]
Abstract
Metabolism during pregnancy is a dynamic and precisely programmed process, the failure of which can bring devastating consequences to the mother and fetus. To define a high-resolution temporal profile of metabolites during healthy pregnancy, we analyzed the untargeted metabolome of 784 weekly blood samples from 30 pregnant women. Broad changes and a highly choreographed profile were revealed: 4,995 metabolic features (of 9,651 total), 460 annotated compounds (of 687 total), and 34 human metabolic pathways (of 48 total) were significantly changed during pregnancy. Using linear models, we built a metabolic clock with five metabolites that time gestational age in high accordance with ultrasound (R = 0.92). Furthermore, two to three metabolites can identify when labor occurs (time to delivery within two, four, and eight weeks, AUROC ≥ 0.85). Our study represents a weekly characterization of the human pregnancy metabolome, providing a high-resolution landscape for understanding pregnancy with potential clinical utilities. Weekly metabolome of maternal blood changes dynamically through healthy pregnancy A metabolic clock of five blood metabolites accurately predicts gestational age Two to three metabolites identify labor onset within two, four, and eight weeks Women with metabolic clocks that outpaced ultrasound evaluation tend to deliver earlier
Collapse
Affiliation(s)
- Liang Liang
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | | | - Brian Piening
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Xiaotao Shen
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Songjie Chen
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Hannes Röst
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - John K Snyder
- Department of Chemistry and the Chemical Instrumentation Center, Boston University, Boston, Massachusetts 02215, USA
| | - Robert Tibshirani
- Department of Statistics and Biomedical Data Science, Stanford University, Stanford, CA 94305, USA
| | - Line Skotte
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, 2300, Denmark
| | - Norman Cy Lee
- Department of Chemistry and the Chemical Instrumentation Center, Boston University, Boston, Massachusetts 02215, USA
| | - Kévin Contrepois
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Bjarke Feenstra
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, 2300, Denmark
| | - Hanyah Zackriah
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA
| | - Michael Snyder
- Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
| | - Mads Melbye
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, 2300, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, 2200, Denmark; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
| |
Collapse
|
161
|
Walters WP, Barzilay R. Applications of Deep Learning in Molecule Generation and Molecular Property Prediction. Acc Chem Res 2021; 54:263-270. [PMID: 33370107 DOI: 10.1021/acs.accounts.0c00699] [Citation(s) in RCA: 107] [Impact Index Per Article: 35.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Recent advances in computer hardware and software have led to a revolution in deep neural networks that has impacted fields ranging from language translation to computer vision. Deep learning has also impacted a number of areas in drug discovery, including the analysis of cellular images and the design of novel routes for the synthesis of organic molecules. While work in these areas has been impactful, a complete review of the applications of deep learning in drug discovery would be beyond the scope of a single Account. In this Account, we will focus on two key areas where deep learning has impacted molecular design: the prediction of molecular properties and the de novo generation of suggestions for new molecules.One of the most significant advances in the development of quantitative structure-activity relationships (QSARs) has come from the application of deep learning methods to the prediction of the biological activity and physical properties of molecules in drug discovery programs. Rather than employing the expert-derived chemical features typically used to build predictive models, researchers are now using deep learning to develop novel molecular representations. These representations, coupled with the ability of deep neural networks to uncover complex, nonlinear relationships, have led to state-of-the-art performance. While deep learning has changed the way that many researchers approach QSARs, it is not a panacea. As with any other machine learning task, the design of predictive models is dependent on the quality, quantity, and relevance of available data. Seemingly fundamental issues, such as optimal methods for creating a training set, are still open questions for the field. Another critical area that is still the subject of multiple research efforts is the development of methods for assessing the confidence in a model.Deep learning has also contributed to a renaissance in the application of de novo molecule generation. Rather than relying on manually defined heuristics, deep learning methods learn to generate new molecules based on sets of existing molecules. Techniques that were originally developed for areas such as image generation and language translation have been adapted to the generation of molecules. These deep learning methods have been coupled with the predictive models described above and are being used to generate new molecules with specific predicted biological activity profiles. While these generative algorithms appear promising, there have been only a few reports on the synthesis and testing of molecules based on designs proposed by generative models. The evaluation of the diversity, quality, and ultimate value of molecules produced by generative models is still an open question. While the field has produced a number of benchmarks, it has yet to agree on how one should ultimately assess molecules "invented" by an algorithm.
Collapse
Affiliation(s)
- W. Patrick Walters
- Relay Therapeutics, 399 Binney Street, Cambridge, Massachusetts 02142, United States
| | - Regina Barzilay
- Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
162
|
Sakai M, Nagayasu K, Shibui N, Andoh C, Takayama K, Shirakawa H, Kaneko S. Prediction of pharmacological activities from chemical structures with graph convolutional neural networks. Sci Rep 2021; 11:525. [PMID: 33436854 PMCID: PMC7803991 DOI: 10.1038/s41598-020-80113-7] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 12/17/2020] [Indexed: 01/29/2023] Open
Abstract
Many therapeutic drugs are compounds that can be represented by simple chemical structures, which contain important determinants of affinity at the site of action. Recently, graph convolutional neural network (GCN) models have exhibited excellent results in classifying the activity of such compounds. For models that make quantitative predictions of activity, more complex information has been utilized, such as the three-dimensional structures of compounds and the amino acid sequences of their respective target proteins. As another approach, we hypothesized that if sufficient experimental data were available and there were enough nodes in hidden layers, a simple compound representation would quantitatively predict activity with satisfactory accuracy. In this study, we report that GCN models constructed solely from the two-dimensional structural information of compounds demonstrated a high degree of activity predictability against 127 diverse targets from the ChEMBL database. Using the information entropy as a metric, we also show that the structural diversity had less effect on the prediction performance. Finally, we report that virtual screening using the constructed model identified a new serotonin transporter inhibitor with activity comparable to that of a marketed drug in vitro and exhibited antidepressant effects in behavioural studies.
Collapse
Affiliation(s)
- Miyuki Sakai
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan ,Medical Database Ltd., 2-5-5 Sumitomoshibadaimon building, Shibadaimon, Minato-ku, Tokyo, 105-0012 Japan
| | - Kazuki Nagayasu
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Norihiro Shibui
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Chihiro Andoh
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Kaito Takayama
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Hisashi Shirakawa
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| | - Shuji Kaneko
- grid.258799.80000 0004 0372 2033Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8501 Japan
| |
Collapse
|
163
|
Shamsara J. Evaluation of the performance of various machine learning methods on the discrimination of the active compounds. Chem Biol Drug Des 2021; 97:930-943. [DOI: 10.1111/cbdd.13819] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2020] [Revised: 12/10/2020] [Accepted: 12/21/2020] [Indexed: 12/12/2022]
Affiliation(s)
- Jamal Shamsara
- Pharmaceutical Research Center Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran
| |
Collapse
|
164
|
Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases. WIRES COMPUTATIONAL MOLECULAR SCIENCE 2021. [DOI: 10.1002/wcms.1513] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
165
|
Dybowski R. Artificial Intelligence in Medicine: Biochemical 3D Modeling and Drug Discovery. Artif Intell Med 2021. [DOI: 10.1007/978-3-030-58080-3_318-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
166
|
Balcells D, Skjelstad BB. tmQM Dataset-Quantum Geometries and Properties of 86k Transition Metal Complexes. J Chem Inf Model 2020; 60:6135-6146. [PMID: 33166143 PMCID: PMC7768608 DOI: 10.1021/acs.jcim.0c01041] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Indexed: 12/19/2022]
Abstract
We report the transition metal quantum mechanics (tmQM) data set, which contains the geometries and properties of a large transition metal-organic compound space. tmQM comprises 86,665 mononuclear complexes extracted from the Cambridge Structural Database, including Werner, bioinorganic, and organometallic complexes based on a large variety of organic ligands and 30 transition metals (the 3d, 4d, and 5d from groups 3 to 12). All complexes are closed-shell, with a formal charge in the range {+1, 0, -1}e. The tmQM data set provides the Cartesian coordinates of all metal complexes optimized at the GFN2-xTB level, and their molecular size, stoichiometry, and metal node degree. The quantum properties were computed at the DFT(TPSSh-D3BJ/def2-SVP) level and include the electronic and dispersion energies, highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energies, HOMO/LUMO gap, dipole moment, and natural charge of the metal center; GFN2-xTB polarizabilities are also provided. Pairwise representations showed the low correlation between these properties, providing nearly continuous maps with unusual regions of the chemical space, for example, complexes combining large polarizabilities with wide HOMO/LUMO gaps and complexes combining low-energy HOMO orbitals with electron-rich metal centers. The tmQM data set can be exploited in the data-driven discovery of new metal complexes, including predictive models based on machine learning. These models may have a strong impact on the fields in which transition metal chemistry plays a key role, for example, catalysis, organic synthesis, and materials science. tmQM is an open data set that can be downloaded free of charge from https://github.com/bbskjelstad/tmqm.
Collapse
Affiliation(s)
- David Balcells
- Hylleraas
Centre for Quantum Molecular Sciences, Department of Chemistry, University of Oslo, P.O. Box 1033, Blindern, 0315 Oslo, Norway
| | - Bastian Bjerkem Skjelstad
- Institute
for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo 001-0021, Japan
| |
Collapse
|
167
|
Bender A, Cortés-Ciriano I. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discov Today 2020; 26:511-524. [PMID: 33346134 DOI: 10.1016/j.drudis.2020.12.009] [Citation(s) in RCA: 95] [Impact Index Per Article: 23.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 09/07/2020] [Accepted: 12/11/2020] [Indexed: 12/30/2022]
Abstract
Although artificial intelligence (AI) has had a profound impact on areas such as image recognition, comparable advances in drug discovery are rare. This article quantifies the stages of drug discovery in which improvements in the time taken, success rate or affordability will have the most profound overall impact on bringing new drugs to market. Changes in clinical success rates will have the most profound impact on improving success in drug discovery; in other words, the quality of decisions regarding which compound to take forward (and how to conduct clinical trials) are more important than speed or cost. Although current advances in AI focus on how to make a given compound, the question of which compound to make, using clinical efficacy and safety-related end points, has received significantly less attention. As a consequence, current proxy measures and available data cannot fully utilize the potential of AI in drug discovery, in particular when it comes to drug efficacy and safety in vivo. Thus, addressing the questions of which data to generate and which end points to model will be key to improving clinically relevant decision-making in the future.
Collapse
Affiliation(s)
- Andreas Bender
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensfield Road CB2 1EW, UK; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
| | - Isidro Cortés-Ciriano
- European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge CB10 1SD, UK.
| |
Collapse
|
168
|
Lane TR, Foil DH, Minerali E, Urbina F, Zorn KM, Ekins S. Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery. Mol Pharm 2020; 18:403-415. [PMID: 33325717 DOI: 10.1021/acs.molpharmaceut.0c01013] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Machine learning methods are attracting considerable attention from the pharmaceutical industry for use in drug discovery and applications beyond. In recent studies, we and others have applied multiple machine learning algorithms and modeling metrics and, in some cases, compared molecular descriptors to build models for individual targets or properties on a relatively small scale. Several research groups have used large numbers of datasets from public databases such as ChEMBL in order to evaluate machine learning methods of interest to them. The largest of these types of studies used on the order of 1400 datasets. We have now extracted well over 5000 datasets from CHEMBL for use with the ECFP6 fingerprint and in comparison of our proprietary software Assay Central with random forest, k-nearest neighbors, support vector classification, naïve Bayesian, AdaBoosted decision trees, and deep neural networks (three layers). Model performance was assessed using an array of fivefold cross-validation metrics including area-under-the-curve, F1 score, Cohen's kappa, and Matthews correlation coefficient. Based on ranked normalized scores for the metrics or datasets, all methods appeared comparable, while the distance from the top indicated that Assay Central and support vector classification were comparable. Unlike prior studies which have placed considerable emphasis on deep neural networks (deep learning), no advantage was seen in this case. If anything, Assay Central may have been at a slight advantage as the activity cutoff for each of the over 5000 datasets representing over 570,000 unique compounds was based on Assay Central performance, although support vector classification seems to be a strong competitor. We also applied Assay Central to perform prospective predictions for the toxicity targets PXR and hERG to further validate these models. This work appears to be the largest scale comparison of these machine learning algorithms to date. Future studies will likely evaluate additional databases, descriptors, and machine learning algorithms and further refine the methods for evaluating and comparing such models.
Collapse
Affiliation(s)
- Thomas R Lane
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States
| | - Daniel H Foil
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States
| | - Eni Minerali
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States
| | - Fabio Urbina
- Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7545, United States
| | - Kimberley M Zorn
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States
| | - Sean Ekins
- Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States
| |
Collapse
|
169
|
Özçelik R, Öztürk H, Özgür A, Ozkirimli E. ChemBoost: A Chemical Language Based Approach for Protein - Ligand Binding Affinity Prediction. Mol Inform 2020; 40:e2000212. [PMID: 33225594 DOI: 10.1002/minf.202000212] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Accepted: 11/20/2020] [Indexed: 11/07/2022]
Abstract
Identification of high affinity drug-target interactions is a major research question in drug discovery. Proteins are generally represented by their structures or sequences. However, structures are available only for a small subset of biomolecules and sequence similarity is not always correlated with functional similarity. We propose ChemBoost, a chemical language based approach for affinity prediction using SMILES syntax. We hypothesize that SMILES is a codified language and ligands are documents composed of chemical words. These documents can be used to learn chemical word vectors that represent words in similar contexts with similar vectors. In ChemBoost, the ligands are represented via chemical word embeddings, while the proteins are represented through sequence-based features and/or chemical words of their ligands. Our aim is to process the patterns in SMILES as a language to predict protein-ligand affinity, even when we cannot infer the function from the sequence. We used eXtreme Gradient Boosting to predict protein-ligand affinities in KIBA and BindingDB data sets. ChemBoost was able to predict drug-target binding affinity as well as or better than state-of-the-art machine learning systems. When powered with ligand-centric representations, ChemBoost was more robust to the changes in protein sequence similarity and successfully captured the interactions between a protein and a ligand, even if the protein has low sequence similarity to the known targets of the ligand.
Collapse
Affiliation(s)
- Rıza Özçelik
- Department of Computer Engineering, Boğaziçi University, Istanbul, Turkey
| | - Hakime Öztürk
- Department of Computer Engineering, Boğaziçi University, Istanbul, Turkey
| | - Arzucan Özgür
- Department of Computer Engineering, Boğaziçi University, Istanbul, Turkey
| | - Elif Ozkirimli
- Department of Chemical Engineering, Boğaziçi University, Istanbul, Turkey.,Data and Analytics Chapter, Pharma International Informatics, F. Hoffmann-La Roche AG, Switzerland
| |
Collapse
|
170
|
Wieder O, Kohlbacher S, Kuenemann M, Garon A, Ducrot P, Seidel T, Langer T. A compact review of molecular property prediction with graph neural networks. DRUG DISCOVERY TODAY. TECHNOLOGIES 2020; 37:1-12. [PMID: 34895648 DOI: 10.1016/j.ddtec.2020.11.009] [Citation(s) in RCA: 102] [Impact Index Per Article: 25.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 11/25/2020] [Accepted: 11/30/2020] [Indexed: 05/22/2023]
Abstract
As graph neural networks are becoming more and more powerful and useful in the field of drug discovery, many pharmaceutical companies are getting interested in utilizing these methods for their own in-house frameworks. This is especially compelling for tasks such as the prediction of molecular properties which is often one of the most crucial tasks in computer-aided drug discovery workflows. The immense hype surrounding these kinds of algorithms has led to the development of many different types of promising architectures and in this review we try to structure this highly dynamic field of AI-research by collecting and classifying 80 GNNs that have been used to predict more than 20 molecular properties using 48 different datasets.
Collapse
Affiliation(s)
- Oliver Wieder
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria
| | - Stefan Kohlbacher
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria
| | - Mélaine Kuenemann
- Servier Research Institute - CentEx Biotechnology, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France
| | - Arthur Garon
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria
| | - Pierre Ducrot
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria
| | - Thomas Seidel
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria
| | - Thierry Langer
- University of Vienna, Department of Pharmaceutical Chemistry, Althanstraße 14, A-1090 Vienna, Austria.
| |
Collapse
|
171
|
Cáceres EL, Mew NC, Keiser MJ. Adding Stochastic Negative Examples into Machine Learning Improves Molecular Bioactivity Prediction. J Chem Inf Model 2020; 60:5957-5970. [PMID: 33245237 DOI: 10.1021/acs.jcim.0c00565] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Multitask deep neural networks learn to predict ligand-target binding by example, yet public pharmacological data sets are sparse, imbalanced, and approximate. We constructed two hold-out benchmarks to approximate temporal and drug-screening test scenarios, whose characteristics differ from a random split of conventional training data sets. We developed a pharmacological data set augmentation procedure, Stochastic Negative Addition (SNA), which randomly assigns untested molecule-target pairs as transient negative examples during training. Under the SNA procedure, drug-screening benchmark performance increases from R2 = 0.1926 ± 0.0186 to 0.4269 ± 0.0272 (122%). This gain was accompanied by a modest decrease in the temporal benchmark (13%). SNA increases in drug-screening performance were consistent for classification and regression tasks and outperformed y-randomized controls. Our results highlight where data and feature uncertainty may be problematic and how leveraging uncertainty into training improves predictions of drug-target relationships.
Collapse
Affiliation(s)
- Elena L Cáceres
- Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States
| | - Nicholas C Mew
- Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States
| | - Michael J Keiser
- Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Bakar Computational Health Sciences Institute, Kavli Institute for Fundamental Neuroscience, Institute for Neurodegenerative Diseases, University of California, San Francisco, 675 Nelson Rising Ln NS 416A, San Francisco, California 94143, United States
| |
Collapse
|
172
|
Albahli S, Albattah W. Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems. Curr Med Imaging 2020; 17:973-980. [PMID: 33231160 PMCID: PMC8653418 DOI: 10.2174/1573405616666201123120417] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2020] [Revised: 09/24/2020] [Accepted: 10/06/2020] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Automatic prediction of COVID-19 using deep convolution neural networks based pre-trained transfer models and Chest X-ray images. METHODS This research employs the advantages of computer vision and medical image analysis to develop an automated model that has the clinical potential for early detection of the disease. Using Deep Learning models, the research aims at evaluating the effectiveness and accuracy of different convolutional neural networks models in the automatic diagnosis of COVID-19 from X-ray images as compared to diagnosis performed by experts in the medical community. RESULTS Due to the fact that the dataset available for COVID-19 is still limited, the best model to use is the InceptionNetV3. Performance results show that the InceptionNetV3 model yielded the highest accuracy of 98.63% (with data augmentation) and 98.90% (without data augmentation) among the three models designed. However, as the dataset gets bigger, the Inception ResNetV2 and NASNetlarge will do a better job of classification. All the performed networks tend to over-fit when data augmentation is not used, this is due to the small amount of data used for training and validation. CONCLUSION A deep transfer learning is proposed to detecting the COVID-19 automatically from chest X-ray by training it with X-ray images gotten from both COVID-19 patients and people with normal chest X-rays. The study is aimed at helping doctors in making decisions in their clinical practice due its high performance and effectiveness, the study also gives an insight to how transfer learning was used to automatically detect the COVID-19.
Collapse
Affiliation(s)
- Saleh Albahli
- Department of Information Technology, College of Computer, Qassim University, Buraydah, Saudi Arabia
| | - Waleed Albattah
- Department of Information Technology, College of Computer, Qassim University, Buraydah, Saudi Arabia
| |
Collapse
|
173
|
Devogelaer J, Meekes H, Tinnemans P, Vlieg E, Gelder R. Co‐crystal Prediction by Artificial Neural Networks**. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202009467] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Jan‐Joris Devogelaer
- Radboud University Institute for Molecules and Materials Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands
| | - Hugo Meekes
- Radboud University Institute for Molecules and Materials Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands
| | - Paul Tinnemans
- Radboud University Institute for Molecules and Materials Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands
| | - Elias Vlieg
- Radboud University Institute for Molecules and Materials Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands
| | - René Gelder
- Radboud University Institute for Molecules and Materials Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands
| |
Collapse
|
174
|
Devogelaer J, Meekes H, Tinnemans P, Vlieg E, de Gelder R. Co-crystal Prediction by Artificial Neural Networks*. Angew Chem Int Ed Engl 2020; 59:21711-21718. [PMID: 32797658 PMCID: PMC7756866 DOI: 10.1002/anie.202009467] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Indexed: 12/29/2022]
Abstract
A significant amount of attention has been given to the design and synthesis of co-crystals by both industry and academia because of its potential to change a molecule's physicochemical properties. Yet, difficulties arise when searching for adequate combinations of molecules (or coformers) to form co-crystals, hampering the efficient exploration of the target's solid-state landscape. This paper reports on the application of a data-driven co-crystal prediction method based on two types of artificial neural network models and co-crystal data present in the Cambridge Structural Database. The models accept pairs of coformers and predict whether a co-crystal is likely to form. By combining the output of multiple models of both types, our approach shows to have excellent performance on the proposed co-crystal training and validation sets, and has an estimated accuracy of 80 % for molecules for which previous co-crystallization data is unavailable.
Collapse
Affiliation(s)
- Jan‐Joris Devogelaer
- Radboud UniversityInstitute for Molecules and MaterialsHeyendaalseweg 1356525AJNijmegenThe Netherlands
| | - Hugo Meekes
- Radboud UniversityInstitute for Molecules and MaterialsHeyendaalseweg 1356525AJNijmegenThe Netherlands
| | - Paul Tinnemans
- Radboud UniversityInstitute for Molecules and MaterialsHeyendaalseweg 1356525AJNijmegenThe Netherlands
| | - Elias Vlieg
- Radboud UniversityInstitute for Molecules and MaterialsHeyendaalseweg 1356525AJNijmegenThe Netherlands
| | - René de Gelder
- Radboud UniversityInstitute for Molecules and MaterialsHeyendaalseweg 1356525AJNijmegenThe Netherlands
| |
Collapse
|
175
|
Li Y, Liu X, You Z, Li L, Guo J, Wang Z. A computational approach for predicting drug–target interactions from protein sequence and drug substructure fingerprint information. INT J INTELL SYST 2020. [DOI: 10.1002/int.22332] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Yang Li
- School of Computer Science & Cyberspace Security Hainan University Haikou China
| | - Xiao‐zhang Liu
- School of Computer Science & Cyberspace Security Hainan University Haikou China
| | - Zhu‐Hong You
- School of Information Engineering Xijing University Xi'an China
| | - Li‐Ping Li
- School of Information Engineering Xijing University Xi'an China
| | - Jian‐Xin Guo
- School of Information Engineering Xijing University Xi'an China
| | - Zheng Wang
- School of Information Engineering Xijing University Xi'an China
| |
Collapse
|
176
|
Martin LJ, Bowen MT. Comparing Fingerprints for Ligand-Based Virtual Screening: A Fast and Scalable Approach for Unbiased Evaluation. J Chem Inf Model 2020; 60:4536-4545. [PMID: 32955876 DOI: 10.1021/acs.jcim.0c00469] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Ligand-based virtual screening is a useful tool for drug and probe discovery due to its high accessibility and scalability. The recent identification of bias in many data sets that were used in performance evaluation, quantified by the asymmetric validation embedding (AVE) score, has prompted the reanalysis of models to determine which performs best. Based on the understanding that ligand data are made up of blocks of highly correlated instances, we introduce a technique that quickly generates splits with AVE distributed close to zero using a combination of clustering and removal of the most biased data. We used our technique to compare the performance of the Morgan and CATS fingerprints and show that, after debiasing, the implementation of the CATS fingerprint performs significantly better. The code to replicate these results and perform low-bias splits is available at https://github.com/ljmartin/fp_low_ave.
Collapse
Affiliation(s)
- Lewis J Martin
- Brain and Mind Centre, The Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Michael T Bowen
- Brain and Mind Centre, The Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
177
|
Renz P, Van Rompaey D, Wegner JK, Hochreiter S, Klambauer G. On failure modes in molecule generation and optimization. DRUG DISCOVERY TODAY. TECHNOLOGIES 2020; 32-33:55-63. [PMID: 33386095 DOI: 10.1016/j.ddtec.2020.09.003] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 09/08/2020] [Accepted: 09/14/2020] [Indexed: 11/29/2022]
Abstract
There has been a wave of generative models for molecules triggered by advances in the field of Deep Learning. These generative models are often used to optimize chemical compounds towards particular properties or a desired biological activity. The evaluation of generative models remains challenging and suggested performance metrics or scoring functions often do not cover all relevant aspects of drug design projects. In this work, we highlight some unintended failure modes in molecular generation and optimization and how these evade detection by current performance metrics.
Collapse
Affiliation(s)
- Philipp Renz
- LIT AI Lab & Institute for Machine Learning, Johannes Kepler University Linz, Altenberger Strasse 69, A-4040 Linz, Austria
| | - Dries Van Rompaey
- High Dimensional Biology and Discovery Data Sciences, Janssen Research & Development, Janssen Pharmaceutica N.V., Turnhoutseweg 30, Beerse B-2340, Belgium
| | - Jörg Kurt Wegner
- High Dimensional Biology and Discovery Data Sciences, Janssen Research & Development, Janssen Pharmaceutica N.V., Turnhoutseweg 30, Beerse B-2340, Belgium
| | - Sepp Hochreiter
- LIT AI Lab & Institute for Machine Learning, Johannes Kepler University Linz, Altenberger Strasse 69, A-4040 Linz, Austria
| | - Günter Klambauer
- LIT AI Lab & Institute for Machine Learning, Johannes Kepler University Linz, Altenberger Strasse 69, A-4040 Linz, Austria
| |
Collapse
|
178
|
Yang S, Ye Q, Ding J, Yin, Lu A, Chen X, Hou T, Cao D. Current advances in ligand‐based target prediction. WIRES COMPUTATIONAL MOLECULAR SCIENCE 2020. [DOI: 10.1002/wcms.1504] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Su‐Qing Yang
- Xiangya School of Pharmaceutical Sciences Central South University Changsha Hunan China
| | - Qing Ye
- College of Pharmaceutical Sciences Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University Hangzhou, Zhejiang China
| | - Jun‐Jie Ding
- Beijing Institute of Pharmaceutical Chemistry Beijing China
| | - Yin
- Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital Central South University Changsha Hunan China
| | - Ai‐Ping Lu
- Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine Hong Kong Baptist University Hong Kong China
| | - Xiang Chen
- Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital Central South University Changsha Hunan China
| | - Ting‐Jun Hou
- College of Pharmaceutical Sciences Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University Hangzhou, Zhejiang China
| | - Dong‐Sheng Cao
- Xiangya School of Pharmaceutical Sciences Central South University Changsha Hunan China
- Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine Hong Kong Baptist University Hong Kong China
| |
Collapse
|
179
|
Uncovering New Drug Properties in Target-Based Drug-Drug Similarity Networks. Pharmaceutics 2020; 12:pharmaceutics12090879. [PMID: 32947845 PMCID: PMC7557376 DOI: 10.3390/pharmaceutics12090879] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 09/09/2020] [Accepted: 09/10/2020] [Indexed: 01/19/2023] Open
Abstract
Despite recent advances in bioinformatics, systems biology, and machine learning, the accurate prediction of drug properties remains an open problem. Indeed, because the biological environment is a complex system, the traditional approach—based on knowledge about the chemical structures—can not fully explain the nature of interactions between drugs and biological targets. Consequently, in this paper, we propose an unsupervised machine learning approach that uses the information we know about drug–target interactions to infer drug properties. To this end, we define drug similarity based on drug–target interactions and build a weighted Drug–Drug Similarity Network according to the drug–drug similarity relationships. Using an energy-model network layout, we generate drug communities associated with specific, dominant drug properties. DrugBank confirms the properties of 59.52% of the drugs in these communities, and 26.98% are existing drug repositioning hints we reconstruct with our DDSN approach. The remaining 13.49% of the drugs seem not to match the dominant pharmacologic property; thus, we consider them potential drug repurposing hints. The resources required to test all these repurposing hints are considerable. Therefore we introduce a mechanism of prioritization based on the betweenness/degree node centrality. Using betweenness/degree as an indicator of drug repurposing potential, we select Azelaic acid and Meprobamate as a possible antineoplastic and antifungal, respectively. Finally, we use a test procedure based on molecular docking to analyze Azelaic acid and Meprobamate’s repurposing.
Collapse
|
180
|
Mervin LH, Afzal AM, Engkvist O, Bender A. Comparison of Scaling Methods to Obtain Calibrated Probabilities of Activity for Protein–Ligand Predictions. J Chem Inf Model 2020; 60:4546-4559. [DOI: 10.1021/acs.jcim.0c00476] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Lewis H. Mervin
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K
| | - Avid M. Afzal
- Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K
| | - Ola Engkvist
- Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Mölndal SE-431 83, Sweden
| | - Andreas Bender
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge CB2 1TN, U.K
| |
Collapse
|
181
|
Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, MacNair CR, French S, Carfrae LA, Bloom-Ackermann Z, Tran VM, Chiappino-Pepe A, Badran AH, Andrews IW, Chory EJ, Church GM, Brown ED, Jaakkola TS, Barzilay R, Collins JJ. A Deep Learning Approach to Antibiotic Discovery. Cell 2020; 180:688-702.e13. [PMID: 32084340 DOI: 10.1016/j.cell.2020.01.021] [Citation(s) in RCA: 725] [Impact Index Per Article: 181.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2019] [Revised: 12/04/2019] [Accepted: 01/15/2020] [Indexed: 02/06/2023]
Abstract
Due to the rapid emergence of antibiotic-resistant bacteria, there is a growing need to discover new antibiotics. To address this challenge, we trained a deep neural network capable of predicting molecules with antibacterial activity. We performed predictions on multiple chemical libraries and discovered a molecule from the Drug Repurposing Hub-halicin-that is structurally divergent from conventional antibiotics and displays bactericidal activity against a wide phylogenetic spectrum of pathogens including Mycobacterium tuberculosis and carbapenem-resistant Enterobacteriaceae. Halicin also effectively treated Clostridioides difficile and pan-resistant Acinetobacter baumannii infections in murine models. Additionally, from a discrete set of 23 empirically tested predictions from >107 million molecules curated from the ZINC15 database, our model identified eight antibacterial compounds that are structurally distant from known antibiotics. This work highlights the utility of deep learning approaches to expand our antibiotic arsenal through the discovery of structurally distinct antibacterial molecules.
Collapse
Affiliation(s)
- Jonathan M Stokes
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Kevin Yang
- Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Kyle Swanson
- Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Wengong Jin
- Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Andres Cubillos-Ruiz
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
| | - Nina M Donghia
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
| | - Craig R MacNair
- Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8N 3Z5, Canada
| | - Shawn French
- Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8N 3Z5, Canada
| | - Lindsey A Carfrae
- Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8N 3Z5, Canada
| | - Zohar Bloom-Ackermann
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
| | - Victoria M Tran
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
| | - Anush Chiappino-Pepe
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
| | - Ahmed H Badran
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
| | - Ian W Andrews
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
| | - Emma J Chory
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
| | - George M Church
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA 02139, USA
| | - Eric D Brown
- Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8N 3Z5, Canada
| | - Tommi S Jaakkola
- Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Regina Barzilay
- Machine Learning for Pharmaceutical Discovery and Synthesis Consortium, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Abdul Latif Jameel Clinic for Machine Learning in Health, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | - James J Collins
- Department of Biological Engineering, Synthetic Biology Center, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA; Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA 02139, USA; Abdul Latif Jameel Clinic for Machine Learning in Health, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| |
Collapse
|
182
|
Wang C, Wang W, Lu K, Zhang J, Chen P, Wang B. Predicting Drug-Target Interactions with Electrotopological State Fingerprints and Amphiphilic Pseudo Amino Acid Composition. Int J Mol Sci 2020; 21:ijms21165694. [PMID: 32784497 PMCID: PMC7570185 DOI: 10.3390/ijms21165694] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Revised: 08/05/2020] [Accepted: 08/06/2020] [Indexed: 12/13/2022] Open
Abstract
The task of drug-target interaction (DTI) prediction plays important roles in drug development. The experimental methods in DTIs are time-consuming, expensive and challenging. To solve these problems, machine learning-based methods are introduced, which are restricted by effective feature extraction and negative sampling. In this work, features with electrotopological state (E-state) fingerprints for drugs and amphiphilic pseudo amino acid composition (APAAC) for target proteins are tested. E-state fingerprints are extracted based on both molecular electronic and topological features with the same metric. APAAC is an extension of amino acid composition (AAC), which is calculated based on hydrophilic and hydrophobic characters to construct sequence order information. Using the combination of these feature pairs, the prediction model is established by support vector machines. In order to enhance the effectiveness of features, a distance-based negative sampling is proposed to obtain reliable negative samples. It is shown that the prediction results of area under curve for Receiver Operating Characteristic (AUC) are above 98.5% for all the three datasets in this work. The comparison of state-of-the-art methods demonstrates the effectiveness and efficiency of proposed method, which will be helpful for further drug development.
Collapse
Affiliation(s)
- Cheng Wang
- Department of Computer Science & Technology, Tongji University, Shanghai 201804, China;
| | - Wenyan Wang
- School of Electrical & Information Engineering, Anhui University of Technology, Ma’anshan 243002, China; (W.W.); (K.L.)
- Key Laboratory of Power Electronics and Motion Control Anhui Education Department, Ma’anshan 243032, China
| | - Kun Lu
- School of Electrical & Information Engineering, Anhui University of Technology, Ma’anshan 243002, China; (W.W.); (K.L.)
| | - Jun Zhang
- Institutes of Physical Science and Information Technology & School of Internet, Anhui University, Hefei 230601, China;
| | - Peng Chen
- Institutes of Physical Science and Information Technology & School of Internet, Anhui University, Hefei 230601, China;
- Correspondence: (P.C.); (B.W.)
| | - Bing Wang
- Department of Computer Science & Technology, Tongji University, Shanghai 201804, China;
- School of Electrical & Information Engineering, Anhui University of Technology, Ma’anshan 243002, China; (W.W.); (K.L.)
- Key Laboratory of Power Electronics and Motion Control Anhui Education Department, Ma’anshan 243032, China
- Correspondence: (P.C.); (B.W.)
| |
Collapse
|
183
|
Latif S, Usman M, Manzoor S, Iqbal W, Qadir J, Tyson G, Castro I, Razi A, Boulos MNK, Weller A, Crowcroft J. Leveraging Data Science to Combat COVID-19: A Comprehensive Review. IEEE TRANSACTIONS ON ARTIFICIAL INTELLIGENCE 2020; 1:85-103. [PMID: 37982070 PMCID: PMC8545032 DOI: 10.1109/tai.2020.3020521] [Citation(s) in RCA: 54] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 07/07/2020] [Accepted: 08/26/2020] [Indexed: 11/17/2023]
Abstract
COVID-19, an infectious disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organisation (WHO) in March 2020. By mid-August 2020, more than 21 million people have tested positive worldwide. Infections have been growing rapidly and tremendous efforts are being made to fight the disease. In this paper, we attempt to systematise the various COVID-19 research activities leveraging data science, where we define data science broadly to encompass the various methods and tools-including those from artificial intelligence (AI), machine learning (ML), statistics, modeling, simulation, and data visualization-that can be used to store, process, and extract insights from data. In addition to reviewing the rapidly growing body of recent research, we survey public datasets and repositories that can be used for further work to track COVID-19 spread and mitigation strategies. As part of this, we present a bibliometric analysis of the papers produced in this short span of time. Finally, building on these insights, we highlight common challenges and pitfalls observed across the surveyed works. We also created a live resource repository at https://github.com/Data-Science-and-COVID-19/Leveraging-Data-Science-To-Combat-COVID-19-A-Comprehensive-Review that we intend to keep updated with the latest resources including new papers and datasets.
Collapse
Affiliation(s)
- Siddique Latif
- University of Southern QueenslandSpringfieldQueensland4300Australia
- Distributed Sensing Systems Group, Data61CSIROPullenvaleQLD4069Australia
| | - Muhammad Usman
- Seoul National UniversitySeoul08700South Korea
- Center for Artificial Intelligence in Medicine and Imaging, HealthHub Company Ltd.Seoul06524South Korea
| | - Sanaullah Manzoor
- Center for Artificial Intelligence in Medicine and Imaging, HealthHub Company Ltd.Seoul06524South Korea
| | - Waleed Iqbal
- Information Technology UniversityPunjab5400Pakistan
| | | | - Gareth Tyson
- Queen Mary University of LondonLondonE1 4NSU.K.
- Queen Mary University of LondonLondonE1 4NSU.K.
| | | | | | - Maged N. Kamel Boulos
- Turner Institute for Brain and Mental Health & Monash Biomedical Imaging, Monash UniversityMelbourne3800Australia
| | - Adrian Weller
- the School of Information Management, Sun Yat-sen UniversityGuangzhou510006China
- University of CambridgeCambridgeCB2 1PZU.K.
| | - Jon Crowcroft
- Alan Turing InstituteLondonNW1 2DBU.K.
- University of CambridgeCambridgeCB2 1TNU.K.
| |
Collapse
|
184
|
Lin E, Lin CH, Lane HY. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design. Molecules 2020; 25:E3250. [PMID: 32708785 PMCID: PMC7397124 DOI: 10.3390/molecules25143250] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2020] [Revised: 07/11/2020] [Accepted: 07/14/2020] [Indexed: 01/16/2023] Open
Abstract
A growing body of evidence now suggests that artificial intelligence and machine learning techniques can serve as an indispensable foundation for the process of drug design and discovery. In light of latest advancements in computing technologies, deep learning algorithms are being created during the development of clinically useful drugs for treatment of a number of diseases. In this review, we focus on the latest developments for three particular arenas in drug design and discovery research using deep learning approaches, such as generative adversarial network (GAN) frameworks. Firstly, we review drug design and discovery studies that leverage various GAN techniques to assess one main application such as molecular de novo design in drug design and discovery. In addition, we describe various GAN models to fulfill the dimension reduction task of single-cell data in the preclinical stage of the drug development pipeline. Furthermore, we depict several studies in de novo peptide and protein design using GAN frameworks. Moreover, we outline the limitations in regard to the previous drug design and discovery studies using GAN models. Finally, we present a discussion of directions and challenges for future research.
Collapse
Affiliation(s)
- Eugene Lin
- Department of Biostatistics, University of Washington, Seattle, WA 98195, USA;
- Department of Electrical & Computer Engineering, University of Washington, Seattle, WA 98195, USA
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan
| | - Chieh-Hsin Lin
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan
- Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
- School of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
| | - Hsien-Yuan Lane
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan
- Department of Psychiatry, China Medical University Hospital, Taichung 40447, Taiwan
- Brain Disease Research Center, China Medical University Hospital, Taichung 40447, Taiwan
- Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung 41354, Taiwan
| |
Collapse
|
185
|
Allen TEH, Wedlake AJ, Gelžinytė E, Gong C, Goodman JM, Gutsell S, Russell PJ. Neural network activation similarity: a new measure to assist decision making in chemical toxicology. Chem Sci 2020; 11:7335-7348. [PMID: 34123016 PMCID: PMC8159362 DOI: 10.1039/d0sc01637c] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Accepted: 06/23/2020] [Indexed: 12/03/2022] Open
Abstract
Deep learning neural networks, constructed for the prediction of chemical binding at 79 pharmacologically important human biological targets, show extremely high performance on test data (accuracy 92.2 ± 4.2%, MCC 0.814 ± 0.093 and ROC-AUC 0.96 ± 0.04). A new molecular similarity measure, Neural Network Activation Similarity, has been developed, based on signal propagation through the network. This is complementary to standard Tanimoto similarity, and the combined use increases confidence in the computer's prediction of activity for new chemicals by providing a greater understanding of the underlying justification. The in silico prediction of these human molecular initiating events is central to the future of chemical safety risk assessment and improves the efficiency of safety decision making.
Collapse
Affiliation(s)
- Timothy E H Allen
- MRC Toxicology Unit, University of Cambridge Hodgkin Building, Lancaster Road Leicester LE1 7HB UK
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK
| | - Andrew J Wedlake
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK
| | - Elena Gelžinytė
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK
| | - Charles Gong
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK
| | - Jonathan M Goodman
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK
| | - Steve Gutsell
- Unilever Safety and Environmental Assurance Centre, Colworth Science Park Sharnbrook Bedfordshire MK44 1LQ UK
| | - Paul J Russell
- Unilever Safety and Environmental Assurance Centre, Colworth Science Park Sharnbrook Bedfordshire MK44 1LQ UK
| |
Collapse
|
186
|
Yang J, Kwon S, Bae SH, Park KM, Yoon C, Lee JH, Seok C. GalaxySagittarius: Structure- and Similarity-Based Prediction of Protein Targets for Druglike Compounds. J Chem Inf Model 2020; 60:3246-3254. [PMID: 32401021 DOI: 10.1021/acs.jcim.0c00104] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Computational techniques for predicting interactions of proteins and druglike molecules have often been used to search for compounds that bind a given protein with high affinity. More recently, such tools have also been applied to the reverse procedure of searching protein targets for a given compound. Among methods for predicting protein-ligand interactions, ligand-based methods relying on similarity to ligands of known interactions are effective only when similar protein-ligand interactions are known. Receptor-based methods predicting protein-ligand interactions by molecular docking are effective only when high-accuracy receptor structures and binding sites are available. Moreover, the computational cost of molecular docking tends to be too high to be applied to the entire protein structure database. In this paper, an effective target prediction method, which combines ligand similarity-based and receptor structure-based approaches, is introduced. In this method, protein-ligand docking is performed after efficient structure- and similarity-based screening. The enriched protein target database by predicted binding ligands and sites allows detection of protein targets with previously unknown ligand interactions. The method, called GalaxySagittarius, is freely available as a web server at http://galaxy.seoklab.org/sagittarius.
Collapse
Affiliation(s)
- Jinsol Yang
- Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea
| | - Sohee Kwon
- Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea
| | - Sang-Hun Bae
- Dr. Noah Biotech, Gwanggyo Ace Tower 2, 256 Changyoung-daero, Yeongtong-gu, Suwon 16229, Republic of Korea
| | - Kyoung Mii Park
- Dr. Noah Biotech, Gwanggyo Ace Tower 2, 256 Changyoung-daero, Yeongtong-gu, Suwon 16229, Republic of Korea
| | - Changsik Yoon
- Dr. Noah Biotech, Gwanggyo Ace Tower 2, 256 Changyoung-daero, Yeongtong-gu, Suwon 16229, Republic of Korea
| | - Ji-Hyun Lee
- Dr. Noah Biotech, Gwanggyo Ace Tower 2, 256 Changyoung-daero, Yeongtong-gu, Suwon 16229, Republic of Korea
| | - Chaok Seok
- Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea
| |
Collapse
|
187
|
Matsuzaka Y, Uesawa Y. Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library. Molecules 2020; 25:molecules25122764. [PMID: 32549344 PMCID: PMC7356846 DOI: 10.3390/molecules25122764] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Revised: 06/06/2020] [Accepted: 06/12/2020] [Indexed: 02/07/2023] Open
Abstract
The interaction of nuclear receptors (NRs) with chemical compounds can cause dysregulation of endocrine signaling pathways, leading to adverse health outcomes due to the disruption of natural hormones. Thus, identifying possible ligands of NRs is a crucial task for understanding the adverse outcome pathway (AOP) for human toxicity as well as the development of novel drugs. However, the experimental assessment of novel ligands remains expensive and time-consuming. Therefore, an in silico approach with a wide range of applications instead of experimental examination is highly desirable. The recently developed novel molecular image-based deep learning (DL) method, DeepSnap-DL, can produce multiple snapshots from three-dimensional (3D) chemical structures and has achieved high performance in the prediction of chemicals for toxicological evaluation. In this study, we used DeepSnap-DL to construct prediction models of 35 agonist and antagonist allosteric modulators of NRs for chemicals derived from the Tox21 10K library. We demonstrate the high performance of DeepSnap-DL in constructing prediction models. These findings may aid in interpreting the key molecular events of toxicity and support the development of new fields of machine learning to identify environmental chemicals with the potential to interact with NR signaling pathways.
Collapse
|
188
|
Kosugi Y, Hosea N. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Mol Pharm 2020; 17:2299-2309. [PMID: 32478525 DOI: 10.1021/acs.molpharmaceut.9b01294] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The in vitro-in vivo extrapolation (IVIVE) approach for predicting total plasma clearance (CLtot) has been widely used to rank order compounds early in discovery. More recently, a computational machine learning approach utilizing physicochemical descriptors and fingerprints calculated from chemical structure information has emerged, enabling virtual predictions even earlier in discovery. Previously, this approach focused more on in vitro intrinsic clearance (CLint) prediction. Herein, we directly compare these two approaches for predicting CLtot in rats. A structurally diverse set of 1114 compounds with known in vivo CLtot, in vitro CLint, and plasma protein binding was used as the basis for this evaluation. The machine learning models were assessed by validation approaches using the time- and cluster-split training and test sets, and five-fold cross validation. Assessed by five-fold validation, the random forest regression (RF) and radial basis function (RBF) models demonstrated better prediction performance in eight attempted machine learning models. The CLtot values predicted by the RF and RBF models were within two-fold of the observed values for 67.7 and 71.9% of cluster-split test set compounds, respectively, while the predictivity was worse in the time-split dataset. The predictivity of both models tended to be improved by incorporating in vitro parameters, unbound fraction in plasma (fu,p), and CLint. CLtot prediction utilizing in vitro CLint and the well-stirred model, correcting for the fraction unbound in blood, was substantially worse compared to machine learning approaches for the same cluster-split test set. The reason that CLtot is underestimated by IVIVE is not fully explained by considering the calculated microsomal unbound fraction (cfu,mic), extended clearance classification system (ECCS), and omitting high clearance compounds in excess of hepatic blood flow. The analysis suggests that in silico machine learning models may have the power to reduce reliance on or replace in vitro and in vivo studies for chemical structure optimization in early drug discovery.
Collapse
Affiliation(s)
- Yohei Kosugi
- Global DMPK, Takeda California Inc., San Diego, California 92121, United States
| | - Natalie Hosea
- Global DMPK, Takeda California Inc., San Diego, California 92121, United States
| |
Collapse
|
189
|
Irwin BWJ, Levell JR, Whitehead TM, Segall MD, Conduit GJ. Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data. J Chem Inf Model 2020; 60:2848-2857. [PMID: 32478517 DOI: 10.1021/acs.jcim.0c00443] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Contemporary deep learning approaches still struggle to bring a useful improvement in the field of drug discovery because of the challenges of sparse, noisy, and heterogeneous data that are typically encountered in this context. We use a state-of-the-art deep learning method, Alchemite, to impute data from drug discovery projects, including multitarget biochemical activities, phenotypic activities in cell-based assays, and a variety of absorption, distribution, metabolism, and excretion (ADME) endpoints. The resulting model gives excellent predictions for activity and ADME endpoints, offering an average increase in R2 of 0.22 versus quantitative structure-activity relationship methods. The model accuracy is robust to combining data across uncorrelated endpoints and projects with different chemical spaces, enabling a single model to be trained for all compounds and endpoints. We demonstrate improvements in accuracy on the latest chemistry and data when updating models with new data as an ongoing medicinal chemistry project progresses.
Collapse
Affiliation(s)
- Benedict W J Irwin
- Optibrium Limited, Cambridge Innovation Park, Denny End Rd, Cambridge CB25 9PB, U.K.,Cavendish Laboratory, University of Cambridge, 19 JJ Thomson Avenue, Cambridge CB3 0HE, U.K
| | - Julian R Levell
- Constellation Pharmaceuticals Inc., 215 First St Suite 200, Cambridge, Massachusetts 02142, United States
| | - Thomas M Whitehead
- Intellegens Limited, Eagle Labs, 28 Chesterton Road, Cambridge CB4 3AZ, U.K
| | - Matthew D Segall
- Optibrium Limited, Cambridge Innovation Park, Denny End Rd, Cambridge CB25 9PB, U.K
| | - Gareth J Conduit
- Intellegens Limited, Eagle Labs, 28 Chesterton Road, Cambridge CB4 3AZ, U.K.,Cavendish Laboratory, University of Cambridge, 19 JJ Thomson Avenue, Cambridge CB3 0HE, U.K
| |
Collapse
|
190
|
Chen ZH, You ZH, Guo ZH, Yi HC, Luo GX, Wang YB. Prediction of Drug-Target Interactions From Multi-Molecular Network Based on Deep Walk Embedding Model. Front Bioeng Biotechnol 2020; 8:338. [PMID: 32582646 PMCID: PMC7283956 DOI: 10.3389/fbioe.2020.00338] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Accepted: 03/26/2020] [Indexed: 12/16/2022] Open
Abstract
Predicting drug-target interactions (DTIs) is crucial in innovative drug discovery, drug repositioning and other fields. However, there are many shortcomings for predicting DTIs using traditional biological experimental methods, such as the high-cost, time-consumption, low efficiency, and so on, which make these methods difficult to widely apply. As a supplement, the in silico method can provide helpful information for predictions of DTIs in a timely manner. In this work, a deep walk embedding method is developed for predicting DTIs from a multi-molecular network. More specifically, a multi-molecular network, also called molecular associations network, is constructed by integrating the associations among drug, protein, disease, lncRNA, and miRNA. Then, each node can be represented as a behavior feature vector by using a deep walk embedding method. Finally, we compared behavior features with traditional attribute features on an integrated dataset by using various classifiers. The experimental results revealed that the behavior feature could be performed better on different classifiers, especially on the random forest classifier. It is also demonstrated that the use of behavior information is very helpful for addressing the problem of sequences containing both self-interacting and non-interacting pairs of proteins. This work is not only extremely suitable for predicting DTIs, but also provides a new perspective for the prediction of other biomolecules' associations.
Collapse
Affiliation(s)
- Zhan-Heng Chen
- The Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Zhu-Hong You
- The Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Zhen-Hao Guo
- The Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Hai-Cheng Yi
- The Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Gong-Xu Luo
- The Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, China
- University of Chinese Academy of Sciences, Beijing, China
| | - Yan-Bin Wang
- School of Cyber Science and Technology, Zhejiang University, Hangzhou, China
| |
Collapse
|
191
|
Brereton AE, MacKinnon S, Safikhani Z, Reeves S, Alwash S, Shahani V, Windemuth A. Predicting drug properties with parameter-free machine learning: pareto-optimal embedded modeling (POEM). MACHINE LEARNING: SCIENCE AND TECHNOLOGY 2020. [DOI: 10.1088/2632-2153/ab891b] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Abstract
The prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) of small molecules from their molecular structure is a central problem in medicinal chemistry with great practical importance in drug discovery. Creating predictive models conventionally requires substantial trial-and-error for the selection of molecular representations, machine learning (ML) algorithms, and hyperparameter tuning. A generally applicable method that performs well on all datasets without tuning would be of great value but is currently lacking. Here, we describe pareto-optimal embedded modeling (POEM), a similarity-based method for predicting molecular properties. POEM is a non-parametric, supervised ML algorithm developed to generate reliable predictive models without need for optimization. POEM’s predictive strength is obtained by combining multiple different representations of molecular structures in a context-specific manner, while maintaining low dimensionality. We benchmark POEM relative to industry-standard ML algorithms and published results across 17 classifications tasks. POEM performs well in all cases and reduces the risk of overfitting.
Collapse
|
192
|
Cui W, Aouidate A, Wang S, Yu Q, Li Y, Yuan S. Discovering Anti-Cancer Drugs via Computational Methods. Front Pharmacol 2020; 11:733. [PMID: 32508653 PMCID: PMC7251168 DOI: 10.3389/fphar.2020.00733] [Citation(s) in RCA: 107] [Impact Index Per Article: 26.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Accepted: 05/01/2020] [Indexed: 12/24/2022] Open
Abstract
New drug discovery has been acknowledged as a complicated, expensive, time-consuming, and challenging project. It has been estimated that around 12 years and 2.7 billion USD, on average, are demanded for a new drug discovery via traditional drug development pipeline. How to reduce the research cost and speed up the development process of new drug discovery has become a challenging, urgent question for the pharmaceutical industry. Computer-aided drug discovery (CADD) has emerged as a powerful, and promising technology for faster, cheaper, and more effective drug design. Recently, the rapid growth of computational tools for drug discovery, including anticancer therapies, has exhibited a significant and outstanding impact on anticancer drug design, and has also provided fruitful insights into the area of cancer therapy. In this work, we discussed the different subareas of the computer-aided drug discovery process with a focus on anticancer drugs.
Collapse
Affiliation(s)
- Wenqiang Cui
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China
| | - Adnane Aouidate
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
| | - Shouguo Wang
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
| | - Qiuliyang Yu
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
| | - Yanhua Li
- College of Veterinary Medicine, Northeast Agricultural University, Harbin, China
| | - Shuguang Yuan
- Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
| |
Collapse
|
193
|
Yan X, Sedykh A, Wang W, Yan B, Zhu H. Construction of a web-based nanomaterial database by big data curation and modeling friendly nanostructure annotations. Nat Commun 2020; 11:2519. [PMID: 32433469 PMCID: PMC7239871 DOI: 10.1038/s41467-020-16413-3] [Citation(s) in RCA: 53] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Accepted: 04/22/2020] [Indexed: 12/27/2022] Open
Abstract
Modern nanotechnology research has generated numerous experimental data for various nanomaterials. However, the few nanomaterial databases available are not suitable for modeling studies due to the way they are curated. Here, we report the construction of a large nanomaterial database containing annotated nanostructures suited for modeling research. The database, which is publicly available through http://www.pubvinas.com/, contains 705 unique nanomaterials covering 11 material types. Each nanomaterial has up to six physicochemical properties and/or bioactivities, resulting in more than ten endpoints in the database. All the nanostructures are annotated and transformed into protein data bank files, which are downloadable by researchers worldwide. Furthermore, the nanostructure annotation procedure generates 2142 nanodescriptors for all nanomaterials for machine learning purposes, which are also available through the portal. This database provides a public resource for data-driven nanoinformatics modeling research aimed at rational nanomaterial design and other areas of modern computational nanotechnology.
Collapse
Affiliation(s)
- Xiliang Yan
- Institute of Environmental Research at Greater Bay, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou, 510006, China.,The Rutgers Center for Computational and Integrative Biology, Camden, NJ, 08102, USA
| | - Alexander Sedykh
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ, 08102, USA.,Sciome, Research Triangle Park, North Carolina, 27709, USA
| | - Wenyi Wang
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ, 08102, USA
| | - Bing Yan
- Institute of Environmental Research at Greater Bay, Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Guangzhou University, Guangzhou, 510006, China. .,School of Environmental Science and Engineering, Shandong University, Jinan, 250100, China.
| | - Hao Zhu
- The Rutgers Center for Computational and Integrative Biology, Camden, NJ, 08102, USA. .,Department of Chemistry, Rutgers University, Camden, NJ, 08102, USA.
| |
Collapse
|
194
|
Mathai N, Kirchmair J. Similarity-Based Methods and Machine Learning Approaches for Target Prediction in Early Drug Discovery: Performance and Scope. Int J Mol Sci 2020; 21:ijms21103585. [PMID: 32438666 PMCID: PMC7279241 DOI: 10.3390/ijms21103585] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 05/13/2020] [Accepted: 05/16/2020] [Indexed: 12/20/2022] Open
Abstract
Computational methods for predicting the macromolecular targets of drugs and drug-like compounds have evolved as a key technology in drug discovery. However, the established validation protocols leave several key questions regarding the performance and scope of methods unaddressed. For example, prediction success rates are commonly reported as averages over all compounds of a test set and do not consider the structural relationship between the individual test compounds and the training instances. In order to obtain a better understanding of the value of ligand-based methods for target prediction, we benchmarked a similarity-based method and a random forest based machine learning approach (both employing 2D molecular fingerprints) under three testing scenarios: a standard testing scenario with external data, a standard time-split scenario, and a scenario that is designed to most closely resemble real-world conditions. In addition, we deconvoluted the results based on the distances of the individual test molecules from the training data. We found that, surprisingly, the similarity-based approach generally outperformed the machine learning approach in all testing scenarios, even in cases where queries were structurally clearly distinct from the instances in the training (or reference) data, and despite a much higher coverage of the known target space.
Collapse
Affiliation(s)
- Neann Mathai
- Department of Chemistry and Computational Biology Unit (CBU), University of Bergen, N-5020 Bergen, Norway;
| | - Johannes Kirchmair
- Department of Chemistry and Computational Biology Unit (CBU), University of Bergen, N-5020 Bergen, Norway;
- Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, 1090 Vienna, Austria
- Correspondence:
| |
Collapse
|
195
|
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 2020; 47:D930-D940. [PMID: 30398643 PMCID: PMC6323927 DOI: 10.1093/nar/gky1075] [Citation(s) in RCA: 1043] [Impact Index Per Article: 260.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2018] [Accepted: 10/18/2018] [Indexed: 12/31/2022] Open
Abstract
ChEMBL is a large, open-access bioactivity database (https://www.ebi.ac.uk/chembl), previously described in the 2012, 2014 and 2017 Nucleic Acids Research Database Issues. In the last two years, several important improvements have been made to the database and are described here. These include more robust capture and representation of assay details; a new data deposition system, allowing updating of data sets and deposition of supplementary data; and a completely redesigned web interface, with enhanced search and filtering capabilities.
Collapse
Affiliation(s)
- David Mendez
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Anna Gaulton
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - A Patrícia Bento
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Jon Chambers
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Marleen De Veij
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Eloy Félix
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - María Paula Magariños
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.,Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Juan F Mosquera
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Prudence Mutowo
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Michal Nowotka
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - María Gordillo-Marañón
- Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, UK
| | - Fiona Hunter
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Laura Junco
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Grace Mugumbate
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Milagros Rodriguez-Lopez
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Francis Atkinson
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Nicolas Bosc
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Chris J Radoux
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.,Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Aldo Segura-Cabrera
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Anne Hersey
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| | - Andrew R Leach
- European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK
| |
Collapse
|
196
|
Friederich P, Dos Passos Gomes G, De Bin R, Aspuru-Guzik A, Balcells D. Machine learning dihydrogen activation in the chemical space surrounding Vaska's complex. Chem Sci 2020; 11:4584-4601. [PMID: 33224459 PMCID: PMC7659707 DOI: 10.1039/d0sc00445f] [Citation(s) in RCA: 72] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Accepted: 04/06/2020] [Indexed: 12/15/2022] Open
Abstract
A machine learning exploration of the chemical space surrounding Vaska's complex.
Homogeneous catalysis using transition metal complexes is ubiquitously used for organic synthesis, as well as technologically relevant in applications such as water splitting and CO2 reduction. The key steps underlying homogeneous catalysis require a specific combination of electronic and steric effects from the ligands bound to the metal center. Finding the optimal combination of ligands is a challenging task due to the exceedingly large number of possibilities and the non-trivial ligand–ligand interactions. The classic example of Vaska's complex, trans-[Ir(PPh3)2(CO)(Cl)], illustrates this scenario. The ligands of this species activate iridium for the oxidative addition of hydrogen, yielding the dihydride cis-[Ir(H)2(PPh3)2(CO)(Cl)] complex. Despite the simplicity of this system, thousands of derivatives can be formulated for the activation of H2, with a limited number of ligands belonging to the same general categories found in the original complex. In this work, we show how DFT and machine learning (ML) methods can be combined to enable the prediction of reactivity within large chemical spaces containing thousands of complexes. In a space of 2574 species derived from Vaska's complex, data from DFT calculations are used to train and test ML models that predict the H2-activation barrier. In contrast to experiments and calculations requiring several days to be completed, the ML models were trained and used on a laptop on a time-scale of minutes. As a first approach, we combined Bayesian-optimized artificial neural networks (ANN) with features derived from autocorrelation and deltametric functions. The resulting ANNs achieved high accuracies, with mean absolute errors (MAE) between 1 and 2 kcal mol–1, depending on the size of the training set. By using a Gaussian process (GP) model trained with a set of selected features, including fingerprints, accuracy was further enhanced. Remarkably, this GP model minimized the MAE below 1 kcal mol–1, by using only 20% or less of the data available for training. The gradient boosting (GB) method was also used to assess the relevance of the features, which was used for both feature selection and model interpretation purposes. Features accounting for chemical composition, atom size and electronegativity were found to be the most determinant in the predictions. Further, the ligand fragments with the strongest influence on the H2-activation barrier were identified.
Collapse
Affiliation(s)
- Pascal Friederich
- Chemical Physics Theory Group , Department of Chemistry , University of Toronto , Toronto , Ontario M5S 3H6 , Canada.,Institute of Nanotechnology , Karlsruhe Institute of Technology , Hermann-von-Helmholtz-Platz 1 , 76344 Eggenstein-Leopoldshafen , Germany.,Department of Computer Science , University of Toronto , 214 College St. , Toronto , Ontario M5T 3A1 , Canada
| | - Gabriel Dos Passos Gomes
- Chemical Physics Theory Group , Department of Chemistry , University of Toronto , Toronto , Ontario M5S 3H6 , Canada.,Department of Computer Science , University of Toronto , 214 College St. , Toronto , Ontario M5T 3A1 , Canada
| | - Riccardo De Bin
- Department of Mathematics , University of Oslo , P. O. Box 1053, Blindern , N-0316 , Oslo , Norway
| | - Alán Aspuru-Guzik
- Chemical Physics Theory Group , Department of Chemistry , University of Toronto , Toronto , Ontario M5S 3H6 , Canada.,Department of Computer Science , University of Toronto , 214 College St. , Toronto , Ontario M5T 3A1 , Canada.,Vector Institute for Artificial Intelligence , 661 University Ave. Suite 710 , Toronto , Ontario M5G 1M1 , Canada.,Lebovic Fellow , Canadian Institute for Advanced Research (CIFAR) , 661 University Ave , Toronto , ON M5G 1M1 , Canada
| | - David Balcells
- Hylleraas Centre for Quantum Molecular Sciences , Department of Chemistry , University of Oslo , P. O. Box 1033, Blindern , N-0315 , Oslo , Norway .
| |
Collapse
|
197
|
Affiliation(s)
- Günter Klambauer
- Johannes Kepler University , LIT AI Lab & Institute for Machine Learning , 4040 Linz , Austria
| | - Sepp Hochreiter
- Johannes Kepler University , LIT AI Lab & Institute for Machine Learning , 4040 Linz , Austria
| | - Matthias Rarey
- Universität Hamburg , ZBH-Center for Bioinformatics , 20146 Hamburg , Germany
| |
Collapse
|
198
|
Zhao T, Hu Y, Valsdottir LR, Zang T, Peng J. Identifying drug-target interactions based on graph convolutional network and deep neural network. Brief Bioinform 2020; 22:2141-2150. [PMID: 32367110 DOI: 10.1093/bib/bbaa044] [Citation(s) in RCA: 118] [Impact Index Per Article: 29.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 03/05/2020] [Accepted: 03/06/2020] [Indexed: 12/21/2022] Open
Abstract
Identification of new drug-target interactions (DTIs) is an important but a time-consuming and costly step in drug discovery. In recent years, to mitigate these drawbacks, researchers have sought to identify DTIs using computational approaches. However, most existing methods construct drug networks and target networks separately, and then predict novel DTIs based on known associations between the drugs and targets without accounting for associations between drug-protein pairs (DPPs). To incorporate the associations between DPPs into DTI modeling, we built a DPP network based on multiple drugs and proteins in which DPPs are the nodes and the associations between DPPs are the edges of the network. We then propose a novel learning-based framework, 'graph convolutional network (GCN)-DTI', for DTI identification. The model first uses a graph convolutional network to learn the features for each DPP. Second, using the feature representation as an input, it uses a deep neural network to predict the final label. The results of our analysis show that the proposed framework outperforms some state-of-the-art approaches by a large margin.
Collapse
Affiliation(s)
- Tianyi Zhao
- Department of Computer Science at Harbin Institute of Technology. He currently works as a bioinformatician in Beth Israel Deaconess Medical Center
| | - Yang Hu
- Department of Life Science at Harbin Institute of Technology. His expertise is bioinformatics
| | - Linda R Valsdottir
- MS in Biology and works as a scientific writer at the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center in Boston, MA. Her work is focused on helping researchers communicate their findings in an effort to translate novel analytical approaches and clinical expertise into improved outcomes for patients
| | - Tianyi Zang
- School of Computer Science and Technology at Harbin Institute of Technology (HIT), China. Before joining HIT in 2009, he was a research fellow at the Department of Computer Science at University of Oxford, UK. His current research is concerned with biomedical bigdata computing and algorithms, deep-learning algorithms for network data, intelligent recommendation algorithms, and modeling and analysis methods for complex systems
| | - Jiajie Peng
- School of Computer Science at Northwestern Polytechnical University. His expertise is computational biology and machine learning. Availability and implementation: https://github.com/zty2009/GCN-DNN/
| |
Collapse
|
199
|
Prasad S, Brooks BR. A deep learning approach for the blind logP prediction in SAMPL6 challenge. J Comput Aided Mol Des 2020; 34:535-542. [PMID: 32002779 PMCID: PMC8689685 DOI: 10.1007/s10822-020-00292-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Accepted: 01/17/2020] [Indexed: 12/14/2022]
Abstract
Water octanol partition coefficient serves as a measure for the lipophilicity of a molecule and is important in the field of drug discovery. A novel method for computational prediction of logarithm of partition coefficient (logP) has been developed using molecular fingerprints and a deep neural network. The machine learning model was trained on a dataset of 12,000 molecules and tested on 2000 molecules. In this article, we present our results for the blind prediction of logP for the SAMPL6 challenge. While the best submission achieved a RMSE of 0.41 logP units, our submission had a RMSE of 0.61 logP units. Overall, we ranked in the top quarter out of the 92 submissions that were made. Our results show that the deep learning model can be used as a fast, accurate and robust method for high throughput prediction of logP of small molecules.
Collapse
Affiliation(s)
- Samarjeet Prasad
- Biophysics and Biophysical Chemistry, The Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA.
- Laboratory of Computational Biology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20814, USA.
| | - Bernard R Brooks
- Laboratory of Computational Biology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, 20814, USA
| |
Collapse
|
200
|
Scalia G, Grambow CA, Pernici B, Li YP, Green WH. Evaluating Scalable Uncertainty Estimation Methods for Deep Learning-Based Molecular Property Prediction. J Chem Inf Model 2020; 60:2697-2717. [PMID: 32243154 DOI: 10.1021/acs.jcim.9b00975] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Advances in deep neural network (DNN)-based molecular property prediction have recently led to the development of models of remarkable accuracy and generalization ability, with graph convolutional neural networks (GCNNs) reporting state-of-the-art performance for this task. However, some challenges remain, and one of the most important that needs to be fully addressed concerns uncertainty quantification. DNN performance is affected by the volume and the quality of the training samples. Therefore, establishing when and to what extent a prediction can be considered reliable is just as important as outputting accurate predictions, especially when out-of-domain molecules are targeted. Recently, several methods to account for uncertainty in DNNs have been proposed, most of which are based on approximate Bayesian inference. Among these, only a few scale to the large data sets required in applications. Evaluating and comparing these methods has recently attracted great interest, but results are generally fragmented and absent for molecular property prediction. In this paper, we quantitatively compare scalable techniques for uncertainty estimation in GCNNs. We introduce a set of quantitative criteria to capture different uncertainty aspects and then use these criteria to compare MC-dropout, Deep Ensembles, and bootstrapping, both theoretically in a unified framework that separates aleatoric/epistemic uncertainty and experimentally on public data sets. Our experiments quantify the performance of the different uncertainty estimation methods and their impact on uncertainty-related error reduction. Our findings indicate that Deep Ensembles and bootstrapping consistently outperform MC-dropout, with different context-specific pros and cons. Our analysis leads to a better understanding of the role of aleatoric/epistemic uncertainty, also in relation to the target data set features, and highlights the challenge posed by out-of-domain uncertainty.
Collapse
Affiliation(s)
- Gabriele Scalia
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.,Department of Electronics, Information and Bioengineering, Politecnico di Milano, 20133 Milano, Italy
| | - Colin A Grambow
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| | - Barbara Pernici
- Department of Electronics, Information and Bioengineering, Politecnico di Milano, 20133 Milano, Italy
| | - Yi-Pei Li
- Department of Chemical Engineering, National Taiwan University, Taipei 10617, Taiwan
| | - William H Green
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| |
Collapse
|